Halia Therapeutics Receives FDA Orphan Drug Design...
Category : ODD/BTA/FTA Status 25 October 2025Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on therapies that targe...
Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on therapies that targe...
AnnJi Pharmaceutical Co., Ltd. (TWSE: 7754) announced that the U.S. Food and Drug Administration (FD...
Cidara Therapeutics announced that the U.S. FDA has granted Breakthrough Therapy designation for CD3...
"Vicore Pharma Holding AB, unlocking the potential of a novel class of drugs, angiotensin II ty...
Clear Scientific Inc., a clinical-stage biopharmaceutical company, announced today that the U.S. Foo...